WO2008111674A1 - 口腔粘膜貼付ブプレノルフィン製剤の製造方法 - Google Patents

口腔粘膜貼付ブプレノルフィン製剤の製造方法 Download PDF

Info

Publication number
WO2008111674A1
WO2008111674A1 PCT/JP2008/054794 JP2008054794W WO2008111674A1 WO 2008111674 A1 WO2008111674 A1 WO 2008111674A1 JP 2008054794 W JP2008054794 W JP 2008054794W WO 2008111674 A1 WO2008111674 A1 WO 2008111674A1
Authority
WO
WIPO (PCT)
Prior art keywords
production
pharmaceutical preparation
mouth mucosa
buprenorphine
granules
Prior art date
Application number
PCT/JP2008/054794
Other languages
English (en)
French (fr)
Inventor
Fuminori Mukunoki
Tadayo Miyasaka
Original Assignee
Toyo Boseki Kabushiki Kaisha
Fuso Pharmaceutical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Boseki Kabushiki Kaisha, Fuso Pharmaceutical Industries, Ltd. filed Critical Toyo Boseki Kabushiki Kaisha
Priority to CN2008800057888A priority Critical patent/CN101631549B/zh
Priority to JP2009504094A priority patent/JPWO2008111674A1/ja
Priority to EP08722190A priority patent/EP2123275A1/en
Priority to US12/529,140 priority patent/US20100098757A1/en
Publication of WO2008111674A1 publication Critical patent/WO2008111674A1/ja
Priority to IL200950A priority patent/IL200950A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　本発明は、口腔粘膜貼付ブプレノルフィン製剤の製造方法を提供することを目的とする。本発明に係る口腔粘膜貼付ブプレノルフィン製剤の製造方法は、９０％累積径が２００μｍ以下である塩酸ブプレノルフィン結晶を含む速放性層用顆粒を調製する工程；９０％累積径が２５０μｍ以下である塩酸ブプレノルフィン結晶を含む徐放性層用顆粒を調製する工程；および、上記速放性層用顆粒と徐放性層用顆粒を用いて打錠し、二層錠とする工程；を含むことを特徴とする。
PCT/JP2008/054794 2007-03-15 2008-03-14 口腔粘膜貼付ブプレノルフィン製剤の製造方法 WO2008111674A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN2008800057888A CN101631549B (zh) 2007-03-15 2008-03-14 贴附于口腔粘膜的丁丙诺非制剂的制造方法
JP2009504094A JPWO2008111674A1 (ja) 2007-03-15 2008-03-14 口腔粘膜貼付ブプレノルフィン製剤の製造方法
EP08722190A EP2123275A1 (en) 2007-03-15 2008-03-14 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
US12/529,140 US20100098757A1 (en) 2007-03-15 2008-03-14 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
IL200950A IL200950A0 (en) 2007-03-15 2009-09-15 Process for the production of a buprenorphine pharmaceutical composition for administration to mouth mucosa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007066807 2007-03-15
JP2007-066807 2007-03-15

Publications (1)

Publication Number Publication Date
WO2008111674A1 true WO2008111674A1 (ja) 2008-09-18

Family

ID=39759602

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/054794 WO2008111674A1 (ja) 2007-03-15 2008-03-14 口腔粘膜貼付ブプレノルフィン製剤の製造方法

Country Status (7)

Country Link
US (1) US20100098757A1 (ja)
EP (1) EP2123275A1 (ja)
JP (1) JPWO2008111674A1 (ja)
KR (1) KR20090119960A (ja)
CN (1) CN101631549B (ja)
IL (1) IL200950A0 (ja)
WO (1) WO2008111674A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505878A (ja) * 2008-10-14 2012-03-08 マクニール アーベー 複数部分口内剤形及びその使用
JP2014526496A (ja) * 2011-09-19 2014-10-06 オレクソ・アクチエボラゲット オピオイド依存を治療するための新規乱用耐性医薬組成物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101631550A (zh) * 2007-04-02 2010-01-20 东洋纺织株式会社 带状疱疹后神经痛治疗用片剂以及带状疱疹后神经痛的治疗方法
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US9907588B2 (en) 2012-09-06 2018-03-06 Orthohelix Surgical Designs, Inc. Orthopedic dual pocket compression plate and method of surgery
CN104940173B (zh) * 2015-07-09 2017-02-15 力品药业（厦门）有限公司 可溶性芬太尼及其衍生物口颊膜制剂及其制备方法
KR102344420B1 (ko) * 2019-10-11 2021-12-29 원광대학교산학협력단 확장형 구조를 갖는 위체류 약물전달장치 및 이의 제조 방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08291070A (ja) 1995-04-21 1996-11-05 Toyobo Co Ltd 口腔粘膜貼付ブプレノルフィン製剤
JPH08333243A (ja) * 1995-06-05 1996-12-17 Nippon Kayaku Co Ltd 口腔内感触の良好な錠剤
WO2000012063A1 (fr) * 1998-08-26 2000-03-09 Teijin Limited Compositions en poudre s'administrant par voie nasale
JP2001506640A (ja) 1996-12-16 2001-05-22 エルティエス ローマン テラピー−ズュステーメ アーゲー ブプレノルフィンまたは薬理学上同等物質の口腔における投与及び放出用の平らな製剤、並びにその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
CN101631550A (zh) * 2007-04-02 2010-01-20 东洋纺织株式会社 带状疱疹后神经痛治疗用片剂以及带状疱疹后神经痛的治疗方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08291070A (ja) 1995-04-21 1996-11-05 Toyobo Co Ltd 口腔粘膜貼付ブプレノルフィン製剤
JPH08333243A (ja) * 1995-06-05 1996-12-17 Nippon Kayaku Co Ltd 口腔内感触の良好な錠剤
JP2001506640A (ja) 1996-12-16 2001-05-22 エルティエス ローマン テラピー−ズュステーメ アーゲー ブプレノルフィンまたは薬理学上同等物質の口腔における投与及び放出用の平らな製剤、並びにその製造方法
WO2000012063A1 (fr) * 1998-08-26 2000-03-09 Teijin Limited Compositions en poudre s'administrant par voie nasale

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MATSUMOTO M. ET AL.: "Yakuzaigaku Manual", vol. 1ST ED., 20 March 1989, NANZANDO CO., LTD., pages: 80, XP008142844 *
OKANO S. ET AL.: "Shin Yakuzaigaku Soron", vol. ED. 3, 10 April 1987, NANKODO CO., LTD., pages: 109, XP008142843 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505878A (ja) * 2008-10-14 2012-03-08 マクニール アーベー 複数部分口内剤形及びその使用
JP2014526496A (ja) * 2011-09-19 2014-10-06 オレクソ・アクチエボラゲット オピオイド依存を治療するための新規乱用耐性医薬組成物

Also Published As

Publication number Publication date
CN101631549A (zh) 2010-01-20
KR20090119960A (ko) 2009-11-23
EP2123275A1 (en) 2009-11-25
JPWO2008111674A1 (ja) 2010-06-24
IL200950A0 (en) 2010-05-17
CN101631549B (zh) 2012-08-22
US20100098757A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2008111674A1 (ja) 口腔粘膜貼付ブプレノルフィン製剤の製造方法
ZA200808631B (en) Solid oral form of a medicinal preparation and a method for the production thereof
PL1598333T3 (pl) Sposób syntezy (1S)-4,5-dimetoksy-1-(metyloaminometylo)benzocyklobutanu i jego soli addycyjnych, oraz zastosowanie do syntezy iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem
WO2011084593A3 (en) Abuse-resistant formulations
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2007091276A3 (en) Novel crystal form of omeprazol sodium
WO2009077188A8 (en) Tea composition and process for the manufacture thereof
WO2005079759A3 (en) Pharmaceutical composition for oral application and method for preparing thereof
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2011131370A8 (en) Melt-granulated fingolimod
WO2008034912A3 (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
PL1589014T3 (pl) Sposób syntezy pochodnych 1,3-dihydro-2H-3-benzazepin-2-onu i jego zastosowanie do wytwarzania iwabradyny i jej dopuszczalnych farmaceutycznie soli
JP2009091362A5 (ja)
WO2010130393A3 (de) Schmelztablette, enthaltend ein vardenafil-salz
WO2009080745A3 (de) Perhydrochinoxalin-derivate als analgetika
WO2009060064A3 (en) Pharmaceutical formulations for the oral administration of ppi
IL183104A0 (en) Method for production of candesartan
WO2009013594A3 (en) Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process
WO2008105533A1 (ja) カプシノイド化合物含有アディポネクチン分泌促進剤
MX2009004647A (es) Proceso para la preparacion de trifluoroetoxitoluenos.
WO2011077406A3 (en) Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880005788.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08722190

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009504094

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020097013418

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 12529140

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2008722190

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200950

Country of ref document: IL

NENP Non-entry into the national phase

Ref country code: DE